THINK Surgical's Milestone: 5,000 Procedures with TMINI®
On May 27, 2026, THINK Surgical, Inc., a key player in the realm of orthopedic surgical robotics, proudly announced a groundbreaking achievement: the successful completion of the 5,000th procedure utilizing its TMINI® Miniature Robotic System. This milestone was reached under the skilled hands of Dr. John Tiberi at Cedars-Sinai Orthopedics in Los Angeles, California.
The TMINI® System has been making waves in the orthopedic community, especially with the rapid increase in its adoption. Achieving 5,000 total knee arthroplasties within such a short time reflects the system’s growing popularity—just a year prior, THINK Surgical celebrated the completion of its 1,000th case. This fivefold increase in volume is attributed to the robust dual-channel commercial strategy that THINK employs, coupled with the exclusive distribution partnership with Zimmer Biomet, which has significantly enhanced the visibility and accessibility of the TMINI® System.
Expanding Compatibility for Improved Care
One of the standout features of the TMINI® System is its open platform nature, which allows surgeons to select from a myriad of implant options tailored to their patients' unique needs. The continuous updates to this platform bolster its versatility; recent enhancements include newly announced compatibility with the Stryker® Triathlon® Knee System in February 2026. This update elevates the TMINI®'s market coverage to approximately 70% of the U.S. implant volume, making a compelling case for its adoption among orthopedic surgeons and healthcare administrators alike.
Dr. Tiberi, who has been utilizing robotics in surgery since 2013, shared his enthusiasm for the TMINI® System, stating, "TMINI is the most versatile knee replacement robotic system that I've seen. The operating room form factor has been well received by my team and the open platform options have allowed for seamless adoption of modern implants."
Growth Driven by Surgeon Demand
Stuart Simpson, President and CEO of THINK Surgical, emphasized the significance of this milestone in the context of rapid operational growth. He noted that the combination of new implant modules introduced within the open-platform TMINI® and the accelerating exclusivity of their partnership with Zimmer Biomet are pivotal factors driving this increased adoption. The TMINI® System's reputation among orthopedic professionals is marked by its ability to modernize and enhance surgical outcomes, addressing patients suffering from advanced joint diseases through accurate and intelligent robotic technology.
THINK Surgical is not just committed to advancing technology; it is also dedicated to patient well-being and clinical efficacy. The company collaborates closely with healthcare professionals across the globe, continuously refining its robotic systems to improve patient outcomes.
As the TMINI® System continues to make strides in the field of orthopedic surgery, it symbolizes a significant leap forward in technological innovation and patient care. Those interested in learning more about the TMINI Miniature Robotic System can visit
THINK Surgical's website for comprehensive information and resources regarding indications, contraindications, and other essential details relating to the system.
With a promising future ahead, THINK Surgical looks poised to redefine the orthopedic experience for both surgeons and patients through its commitment to innovation and excellence in robotic-assisted surgery.